irinotecan,avelumab,domvanalimab,zimberelimab,sacituzumab govitecan,sacituzumab govitecan,pembrolizumab,sacituzumab govitecan
merck,otsuka,gilead sciences,pfizer,gilead sciences,arcus biosciences
['muc ,(-much)', 'sacituzumab', 'irinotecan', 'trophy,u-01', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'sacitu, govi']
primary analysis of #trophy-u-01 cohort 2, a phase 2 study of sacituzumab govitecan in platinum-ineligible pts with #muc that progressed after prior checkpoint inhibitor therapy . #gu23 coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology